These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12771857)

  • 21. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment.
    Salomon O; Steinberg DM; Zivelin A; Gitel S; Dardik R; Rosenberg N; Berliner S; Inbal A; Many A; Lubetsky A; Varon D; Martinowitz U; Seligsohn U
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):511-8. PubMed ID: 10073951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of the prothrombin gene 20201 GA variant in FV:Q506 carriers in relationship to the presence or absence of juvenile venous thromboembolism.
    Ehrenforth S; von Depka Prondsinski M; Aygören-Pürsün E; Nowak-Göttl U; Scharrer I; Ganser A
    Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):276-80. PubMed ID: 9974407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
    Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
    J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis.
    Nizankowska-Mogilnicka E; Adamek L; Grzanka P; Domagala TB; Sanak M; Krzanowski M; Szczeklik A
    Eur Respir J; 2003 Jan; 21(1):25-30. PubMed ID: 12570104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Rossi E; Chiusolo P; Casorelli I; Leone G
    Br J Haematol; 2001 Jun; 113(3):630-5. PubMed ID: 11380448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prothrombin G20210A gene mutation with LightCycler polymerase chain reaction in venous thrombosis and healthy population in the southeast of Turkey.
    Ayyildiz O; Kalkanli S; Batun S; Aybak M; Isikdogan A; Tiftik N; Bolaman Z; Soker M; Muftuoglu E
    Heart Vessels; 2004 Jul; 19(4):164-6. PubMed ID: 15278388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population.
    Angchaisuksiri P; Pingsuthiwong S; Aryuchai K; Busabaratana M; Sura T; Atichartakarn V; Sritara P
    Am J Hematol; 2000 Oct; 65(2):119-22. PubMed ID: 10996828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of the age in the risk of the prothrombin G20210A mutation for spontaneous venous thrombosis.
    Gutiérrez Tous MR; Couto Caro C; García-Donas Gabaldón G; Viloria Peñas Mdel M; Simón Pilo I; Almeida González C
    Med Clin (Barc); 2007 May; 128(17):652-4. PubMed ID: 17537362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
    Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
    Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
    Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.
    Segal JB; Brotman DJ; Necochea AJ; Emadi A; Samal L; Wilson LM; Crim MT; Bass EB
    JAMA; 2009 Jun; 301(23):2472-85. PubMed ID: 19531787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the factor II: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V: R506Q mutation.
    Rintelen C; Pabinger I; Bettelheim P; Lechner K; Kyrle PA; Knöbl P; Schneider B; Mannhalter C
    Eur J Haematol; 2001 Sep; 67(3):165-9. PubMed ID: 11737249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism.
    Miles JS; Miletich JP; Goldhaber SZ; Hennekens CH; Ridker PM
    J Am Coll Cardiol; 2001 Jan; 37(1):215-8. PubMed ID: 11153741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of factor V Leiden and prothrombin G20101A mutations in Kashmiri patients with venous thromboembolism.
    Shafia S; Zargar MH; Khan N; Ahmad R; Shah ZA; Asimi R
    Gene; 2018 May; 654():1-9. PubMed ID: 29454086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venous thromboembolism, oral contraceptives and high prothrombin levels.
    Legnani C; Cosmi B; Valdrè L; Boggian O; Bernardi F; Coccheri S; Palareti G
    J Thromb Haemost; 2003 Jan; 1(1):112-7. PubMed ID: 12871547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma fibrin clot properties in the G20210A prothrombin mutation carriers following venous thromboembolism: the effect of rivaroxaban.
    Janion-Sadowska A; Natorska J; Siudut J; Ząbczyk M; Stanisz A; Undas A
    Thromb Haemost; 2017 Aug; 117(9):1739-1749. PubMed ID: 28771277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
    Marchiori A; Mosena L; Prins MH; Prandoni P
    Haematologica; 2007 Aug; 92(8):1107-14. PubMed ID: 17650440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and Geographical Variation of Prothrombin G20210A Mutation in Patients with Cerebral Vein Thrombosis: A Systematic Review and Meta-Analysis.
    Gonzalez JV; Barboza AG; Vazquez FJ; Gándara E
    PLoS One; 2016; 11(3):e0151607. PubMed ID: 27031503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
    Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic APC resistance in carriers of the A20210 prothrombin mutation is associated with an increased risk of venous thrombosis.
    Castaman G; Tosetto A; Simioni M; Ruggeri M; Madeo D; Rodeghiero F
    Thromb Haemost; 2001 Sep; 86(3):804-8. PubMed ID: 11583311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.